Guardant Health
GH
#1156
Rank
โ‚ฌ17.89 B
Marketcap
132,27ย โ‚ฌ
Share price
1.30%
Change (1 day)
60.28%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -3,00ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -3,18ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,02ย โ‚ฌ an increase over its 2024 EPS that were of -3,24ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,00ย โ‚ฌ-0.39%
2025-3,02ย โ‚ฌ-7.02%
2024-3,24ย โ‚ฌ-16.82%
2023-3,90ย โ‚ฌ-33.13%
2022-5,83ย โ‚ฌ60%
2021-3,65ย โ‚ฌ55.04%
2020-2,35ย โ‚ฌ207.14%
2019-0,77ย โ‚ฌ-19.81%
2018-0,95ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-0,23ย โ‚ฌ-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-2,23ย โ‚ฌ-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA